BrightSpring Health Services

BrightSpring organizes its business into three primary verticals: Provider Services, which includes home health, hospice, and behavioral neurorehabilitation; Pharmacy Services, anchored by brands like PharMerica and Amerita; and Managed Care. This structure is designed to deliver integrated care to seniors, patients with chronic conditions, and individuals requiring specialized behavioral or neurorehabilitation support.

Jon Rousseau serves as President and CEO. Before joining BrightSpring, he spent roughly seven years in private equity at Friedman Fleischer & Lowe and began his career in investment banking at Morgan Stanley. He also held senior roles at Mylan and Medtronic. His background spans capital deployment, corporate strategy, and operating leadership across healthcare services and medical devices.

PharMerica operates as BrightSpring's institutional pharmacy services brand, focusing on medication therapy management for complex populations. It is one of the primary operating subsidiaries within BrightSpring's Pharmacy Services division, alongside the specialty infusion provider Amerita.

BrightSpring delivers care across all 50 states to over 400,000 patients annually through its integrated platform. Its service lines address populations referred through hospital systems, managed care organizations, and government programs. The company's model focuses on absorbing the clinical complexity of high-need patients, which positions it as a consolidator for health systems and payors seeking integrated post-acute and chronic care solutions.

BrightSpring is a public company trading under the ticker BTSG on NASDAQ. Its public status subjects it to regular SEC reporting and governance standards, which is unusual among consolidators of primarily community-based, non-acute healthcare services.